Perrigo Company plc Operating Lease, Payments
Perrigo Company plc (PRGO) reported Operating Lease, Payments of $17.00 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-05
- Perrigo Company plc operating lease, payments for the quarter ending 2026-06-27 was $8.60M, a 8.51% decline year-over-year.
- Perrigo Company plc operating lease, payments for the quarter ending 2026-03-28 was $8.40M, a 8.70% decline year-over-year.
- Perrigo Company plc operating lease, payments for the quarter ending 2025-12-31 was $9.50M, a 7.95% increase year-over-year.
- Perrigo Company plc operating lease, payments for the quarter ending 2025-09-27 was $8.90M, a 7.29% decline year-over-year.
- Perrigo Company plc operating lease, payments for fiscal 2025 was $37.00M, a 4.23% increase from fiscal 2024.
- Perrigo Company plc operating lease, payments for fiscal 2024 was $35.50M, a 0.56% decline from fiscal 2023.
- Perrigo Company plc operating lease, payments for fiscal 2023 was $35.70M, a 9.16% decline from fiscal 2022.
- Perrigo Company plc operating lease, payments for fiscal 2022 was $39.30M, a 17.31% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.00M 10-Q · filed 2026-08-05 | $26.50M derived: sum of 3 quarters · filed 2026-08-05 | $35.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $8.40M 10-Q · filed 2026-05-06 | $17.90M derived: sum of 2 quarters · filed 2026-05-06 | $26.80M derived: sum of 3 quarters · filed 2026-05-06 | $36.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.40M derived: sum of 2 quarters · filed 2026-02-26 | $27.80M derived: sum of 3 quarters · filed 2026-08-05 | $37.00M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $8.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $18.30M derived: sum of 2 quarters · filed 2026-08-05 | $27.50M 10-Q · filed 2025-11-05 | $36.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $9.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $18.60M 10-Q · filed 2026-08-05 | $27.40M derived: sum of 3 quarters · filed 2026-08-05 | $37.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | $9.20M 10-Q · filed 2026-05-06 | $18.00M derived: sum of 2 quarters · filed 2026-05-06 | $27.60M derived: sum of 3 quarters · filed 2026-05-06 | $36.20M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.40M derived: sum of 2 quarters · filed 2026-02-26 | $27.00M derived: sum of 3 quarters · filed 2026-02-26 | $35.50M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | $9.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $18.20M derived: sum of 2 quarters · filed 2025-11-05 | $26.70M 10-Q · filed 2025-11-05 | $35.40M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-29 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $17.10M 10-Q · filed 2025-08-06 | $25.80M derived: sum of 3 quarters · filed 2025-08-06 | $34.60M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-30 | $8.50M 10-Q · filed 2025-05-07 | $17.20M derived: sum of 2 quarters · filed 2025-05-07 | $26.00M derived: sum of 3 quarters · filed 2025-05-07 | $35.20M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $17.50M derived: sum of 2 quarters · filed 2025-02-28 | $26.70M derived: sum of 3 quarters · filed 2025-02-28 | $35.70M 10-K · filed 2025-02-28 | ||||
| 2023-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $18.00M derived: sum of 2 quarters · filed 2024-11-06 | $27.00M 10-Q · filed 2024-11-06 | $35.70M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-07-01 | $9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $18.20M 10-Q · filed 2024-08-02 | $26.90M derived: sum of 3 quarters · filed 2024-08-02 | $40.90M derived: sum of 4 quarters · filed 2024-08-02 | ||||
| 2023-04-01 | $9.00M 10-Q · filed 2024-05-07 | $17.70M derived: sum of 2 quarters · filed 2024-05-07 | $31.70M derived: sum of 3 quarters · filed 2024-05-07 | $39.80M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $22.70M derived: sum of 2 quarters · filed 2024-02-27 | $30.80M derived: sum of 3 quarters · filed 2024-02-27 | $39.30M 10-K · filed 2024-02-27 | ||||
| 2022-10-01 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $22.10M derived: sum of 2 quarters · filed 2023-11-07 | $30.60M 10-Q · filed 2023-11-07 | $37.80M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-07-02 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $16.60M 10-Q · filed 2023-08-08 | $23.80M derived: sum of 3 quarters · filed 2023-08-08 | $31.90M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-04-02 | $8.50M 10-Q · filed 2023-05-09 | $15.70M derived: sum of 2 quarters · filed 2023-05-09 | $23.80M derived: sum of 3 quarters · filed 2023-05-09 | $32.00M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.30M derived: sum of 2 quarters · filed 2023-02-28 | $23.50M derived: sum of 3 quarters · filed 2023-02-28 | $33.50M 10-K · filed 2023-02-28 | ||||
| 2021-10-02 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $16.30M derived: sum of 2 quarters · filed 2022-11-08 | $26.30M 10-Q · filed 2022-11-08 | $35.30M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-07-03 | $8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $18.20M 10-Q · filed 2022-08-09 | $27.20M derived: sum of 3 quarters · filed 2022-08-09 | $35.30M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-04-03 | $10.00M 10-Q · filed 2022-05-11 | $19.00M derived: sum of 2 quarters · filed 2022-05-11 | $27.10M derived: sum of 3 quarters · filed 2022-05-11 | $35.50M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.10M derived: sum of 2 quarters · filed 2022-03-01 | $25.50M derived: sum of 3 quarters · filed 2022-03-01 | $34.40M 10-K · filed 2022-03-01 | $41.90M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $16.50M derived: sum of 2 quarters · filed 2021-11-12 | $25.40M 10-Q · filed 2021-11-12 | $31.20M 10-Q · filed 2020-11-05 | $35.70M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-27 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $17.30M 10-Q · filed 2021-08-11 | $20.40M 10-Q · filed 2020-08-05 | $27.60M derived: sum of 3 quarters · filed 2021-08-11 | $38.20M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-28 | $8.90M 10-Q · filed 2021-05-12 | $10.70M 10-Q · filed 2020-05-05 | $19.20M derived: sum of 2 quarters · filed 2021-05-12 | $29.80M derived: sum of 3 quarters · filed 2021-05-12 | $41.10M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $20.90M derived: sum of 2 quarters · filed 2021-03-01 | $32.20M derived: sum of 3 quarters · filed 2021-03-01 | $43.90M 10-K · filed 2021-03-01 | ||||
| 2019-09-28 | $10.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $21.90M derived: sum of 2 quarters · filed 2020-11-05 | $33.60M 10-Q · filed 2020-11-05 | |||||
| 2019-06-29 | $11.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $23.00M 10-Q · filed 2020-08-05 | ||||||
| 2019-03-30 | $11.70M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |